Grateful hearts, full plates, and cherished moments. This Thanksgiving, let's count blessings, not calories! What are you most thankful for? #Thanksgiving #Gratitude #FamilyFirst #Thanksgiving2024 #HarvestSeason #Blessed #FamilyTime #PumpkinEverything #ThanksgivingFeast
Octanex Labs Pvt. Ltd.
Pharmaceutical Manufacturing
HYDERABAD, TELANGANA 1,321 followers
Contract Research, Custom Synthesis and Manufacturing
About us
Octanex Labs is a privately owned company focusing on the custom synthesis and manufacturing of active ingredients, intermediates, and specialty molecules. We offer contract development and manufacturing services from R&D development to quick scale-up. We want to be a preferred strategic supplier of our value-added chemistry services and products with the highest quality and on-time in full delivery. We are specializing in the synthesis of a wide range of organic compounds to cater to the needs of leading pharma, biotech, agro, animal health, specialty chemical companies, and research institutes across the world. We are located in Hyderabad, the pharma and life sciences hub of India, surrounded by skilled chemistry talent pool, highly reputed research institutes, and startup companies.
- Website
-
http://www.octanexlabs.com
External link for Octanex Labs Pvt. Ltd.
- Industry
- Pharmaceutical Manufacturing
- Company size
- 11-50 employees
- Headquarters
- HYDERABAD, TELANGANA
- Type
- Privately Held
- Founded
- 2017
- Specialties
- Interemdiates, Speciality Molecules, Custom Synthesis, R&D Building Blocks, Contract Research, Library Compounds, Scale up, Novel Compounds, FTE, and FFS
Locations
-
Primary
Plot no 23 road no 03
Aleap industrial estate pragathi nagar
HYDERABAD, TELANGANA 500090, IN
Employees at Octanex Labs Pvt. Ltd.
-
Bhanu Prasad
Student at Sri Venkateswara University
-
Sadasiva Rao Ginjupalli
Technical Lead at OctaneX Labs Pvt Ltd
-
Bhanu Adusumalli
Sales and Procurement Specialist at Octanex Labs Private Limited
-
Janardhan Boyapati
Pharma Entrepreneur | CRO specialized in Small Molecules, Impurities, & Peptide Reagents | Real Estate Developer & Angel Investor
Updates
-
Happy Children’s Day! Celebrating the spirit, innocence, and potential of every child, as we honor Jawaharlal Nehru's belief in the power of young minds to shape the future. Let's nurture, educate, and empower our children for a brighter tomorrow. #ChildrensDay #JawaharlalNehru #FutureLeaders #InspireYoungMinds #CelebrateChildhood #EducationForAll #Nov14
-
Advancing science for better health and a sustainable planet. On this World Science Day, we’re committed to solutions that protect human rights and drive climate action. #WorldScienceDay #ScienceForHealth #BetterHealth #ClimateAction #HumanRights #Innovation #OctaneXLabs
-
From tricks to treats, we're celebrating Halloween with creativity and a dash of fun! Here’s to bringing some festive spirit to the workplace—may your Halloween be filled with inspiration and teamwork! #HalloweenAtWork #CorporateHalloween #SpookySeason #CRO #CDMO #ContractManufacturing #OctaneXLabs
-
May your Diwali sparkle with joy, shine with warmth, and bring abundant happiness to you and your loved ones. Team OctaneX Labs #Diwali2024 #FestivalMagic #JoyAndProsperity #Deepavali #FestivalofLights
-
Octanex Labs Pvt. Ltd. reposted this
Strong Q'2 Growth For Indian Pharma Ahead 💉💊 🩺 Analysts are forecasting strong growth for the pharma sector in Q2FY25, driven by a robust domestic market. Sales and EBITDA for pharma companies are expected to rise by 8-10%, with profit growth potentially hitting 11%, aided by lower interest costs. The domestic formulations business could see a 10-11% growth during the quarter. JB Chemicals is projected to experience over 20% growth, largely due to the success of its ophthalmology division. Torrent Pharma is expected to grow by 12-13%, supported by improved productivity from its market representatives. Dr Reddy’s Laboratories is also set to report over 10% growth, partly driven by its joint venture with Nestlé. In the US market, growth of around 11% is anticipated, fueled by Sun Pharma’s strong specialty sales and niche products like Revlimid generics for Dr Reddy’s and Natco, and Spiriva generics for Lupin. Easing price pressures and resolving drug shortages will also contribute to the sector’s growth. Sumit Gupta, AVP of Research at Centrum, shared on CNBC-TV18 that Sun Pharma’s specialty segment, with reduced reliance on the Revlimid portfolio, will likely drive growth. Additionally, Dr Reddy’s is expected to perform well in the domestic market, benefiting from its Nestlé partnership. JB Chemicals could report a 22% growth, fueled by ophthalmology integration, with base portfolio growth estimated between 12-30%. Earlier this year, Dr Reddy’s and Nestlé teamed up to distribute nutritional health products across India, leveraging Dr Reddy’s extensive retail network. #indianpharma #pharmamanufacturing #sunpharma #pharmaceuticalsales
-
May this Dussehra bring the triumph of positivity, success, and happiness in every aspect of your life. Celebrate the victory of good over evil with love and joy! #HappyDussehra #FestiveVibes #VictoryOfGood #OctaneXLabs #FestivalOfJoy #SuccessAndHappiness
-
Reflecting on our incredible journey at CPHI Milan, Italy! From engaging in discussions to forging meaningful connections, every moment was a testament to our commitment to innovation in the pharma industry. A huge thank you to CPHI for hosting such a phenomenal event! We’re excited to bring these experiences back to OctaneX Labs and continue our mission of advancing chemical processes. Here’s to new partnerships and bright horizons! #OctaneXLabs #PharmaInnovation #CPHIMilan #ChemicalProcesses #PharmaceuticalIndustry #Networking #GlobalPharma #Partnerships #Exhibition #Biotechnolog
-
+1
-
Octanex Labs Pvt. Ltd. reposted this
Day 2 at CPHI Milan has been filled with game-changing insights and discussions. From advanced biopharma tech to precision manufacturing, the ideas exchanged here are shaping the future of the industry. At OctaneX Labs, we’re focused on leveraging these breakthroughs to streamline drug development and scale impactful solutions. Looking forward to forging new partnerships that will drive real progress. #cphi #milan #pharmaindustry #healthcare #pharmaceuticals
-
Join us in Italy from 8th to 10th October to explore innovations, network, and discuss the future of pharmaceuticals. We can’t wait to connect with global leaders and showcase our latest advancements. See you at Fiera Milano—let’s shape the future together! #CPhI2024 #OctaneXLabs #PharmaInnovation #MilanoEvent #GlobalNetworking #Pharmaceuticals #FutureOfMedicine